← FDA Drug Approvals (Drugs@FDA)
EVEROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2020-06-08
Drug application
- FDA Application #
ANDA212936- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EVEROLIMUS
- Generic name
- Everolimus
- Active ingredients
- EVEROLIMUS
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2020-06-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown